Chronic pain: A non-use disease

Medical Hypotheses

Volumn 68, Issue 3, 2007, Pages 506-511

  Pruimboom, L ^a   van Dam, A C ^a  

^a UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; ARTICLE; CHRONIC PAIN; EMOTION; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LOW BACK PAIN; NEUROANATOMY; NEUROLOGIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CHRONIC DISEASE; EMOTIONS; HUMANS; MODELS, NEUROLOGICAL; NEUROGLIA; PAIN;

EID: 33845928590     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.08.036     Document Type: Article

References (31)

1. Watkins L.R., et al. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci 28 12 (2005) 661-669
2. Craig A.D. How do you feel? interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 3 8 (2002) 655-666
3. Taub E., et al. A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke. Stroke 37 4 (2006) 1045-1049
4. Craig A.D. Pain mechanisms: labeled lines versus convergence in central processing. Annu Rev Neurosci 26 (2003) 1-30
5. Craig A.D. Lamina I, but not lamina V, spinothalamic neurons exhibit responses that correspond with burning pain. J Neurophysiol 92 4 (2004) 2604-2609
6. Wieseler-Frank J., Maier S.F., and Watkins L.R. Central proinflammatory cytokines and pain enhancement. Neurosignals 14 4 (2005) 166-174
7. Wieseler-Frank J., Maier S.F., and Watkins L.R. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun 19 2 (2005) 104-111
8. Cami J., and Farre M. Drug addiction. New Engl J Med 349 10 (2003) 975-986
9. Raghavendra V., et al. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104 3 (2003) 655-664
10. Raghavendra V., Tanga F.Y., and DeLeo J.A. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacol 29 2 (2004) 327-334
11. Dorazil-Dudzik M., et al. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth Analg 98 6 (2004) 1566-1573 Table of contents
12. Brooks J.C., et al. Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging. Neuroimage 27 1 (2005) 201-209
13. Raja S.N., et al. Opioids versus antidepressants in postherpetic neuralgia: a randomised, placebo-controlled trial. Neurology 59 7 (2002) 1015-1021
14. Max M.B. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 35 (1994) S50-S53
15. Gilron I., et al. Morphine, gabapentin, or their combination for neuropathic pain. New Engl J Med 352 13 (2005) 1324-1334
16. Mark V.W., and Taub E. Constraint-induced movement therapy for chronic stroke hemiparesis and other disabilities. Restor Neurol Neuros 22 3-5 (2004) 317-336
17. Taub E., Uswatte G., and Pidikiti R. Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation - a clinical review. J Rehabil Res Dev 36 3 (1999) 237-251
18. Poiraudeau S., et al. Fear-avoidance beliefs about back pain in patients with subacute low back pain. Pain (2006)
19. Grotle M., Vollestad N.K., and Brox J.I. Clinical course and impact of fear-avoidance beliefs in low back pain: prospective cohort study of acute and chronic low back pain: II. Spine 31 9 (2006) 1038-1046
20. Boersma K., and Linton S.J. Expectancy, fear and pain in the prediction of chronic pain and disability: a prospective analysis. Eur J Pain 10 6 (2006) 551-557
21. Boersma K., and Linton S.J. Psychological processes underlying the development of a chronic pain problem: a prospective study of the relationship between profiles of psychological variables in the fear-avoidance model and disability. Clin J Pain 22 2 (2006) 160-166
22. Gifford L. Acute low cervical nerve root conditions: symptom presentations and pathobiological reasoning. Manual Ther 6 2 (2001) 106-115
23. Walker L.S., et al. Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain 122 1-2 (2006) 43-52
24. Elbert T., and Rockstroh B. Reorganisation of human cerebral cortex: the range of changes following use and injury. Neuroscientist 10 2 (2004) 129-141
25. Moseley G.L. A pain neuromatrix approach to patients with chronic pain. Manual Ther 8 3 (2003) 130-140
26. Berrendero F., et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25 5 (2005) 1103-1112
27. Schofferman J. Restoration of function: The missing link in pain medicine?. Pain Med 7 Suppl. 1 (2006) S159-S165
28. Cami J., and Farre M. Drug addiction. New Engl J Med 349 10 (2003) 975-986
29. Magora F., et al. Virtual reality immersion method of distraction to control experimental ischemic pain. Israel Med Assoc J 8 4 (2006) 261-265
30. Hoffman H.G. Virtual-reality therapy. Sci Am 291 2 (2004) 58-65
31. Jensen S. Back pain-clinical assessment. Aust Fam Physician 33 6 (2004) 393-395 397-401